Ontology highlight
ABSTRACT: Aims
O-polysaccharide (OPS) molecules are protective antigens for several bacterial pathogens, and have broad utility as components of glycoconjugate vaccines. Variability in the OPS chain length is one obstacle towards further development of these vaccines. Introduction of sizing steps during purification of OPS molecules of suboptimal or of mixed lengths introduces additional costs and complexity while decreasing the final yield. The overall goal of this study was to demonstrate the utility of engineering Gram-negative bacteria to produce homogenous O-polysaccharide populations that can be used as the basis of carbohydrate vaccines by overexpressing O-polysaccharide chain length regulators of the Wzx-/Wzy-dependent pathway.Method and results
The O-polysaccharide chain len
SUBMITTER: Hegerle N
PROVIDER: S-EPMC6726474 | biostudies-literature | 2018 Aug
REPOSITORIES: biostudies-literature